Cite
HARVARD Citation
Decker, J. et al. (2020). Cyclin E overexpression confers resistance to trastuzumab through noncanonical phosphorylation of SMAD3 in HER2+ breast cancer. Cancer biology & therapy. 21 (11), pp. 994-1004. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Decker, J. et al. (2020). Cyclin E overexpression confers resistance to trastuzumab through noncanonical phosphorylation of SMAD3 in HER2+ breast cancer. Cancer biology & therapy. 21 (11), pp. 994-1004. [Online].